Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Carmat SA

Market Cap 6.15M 7.13M 5.66M 5.31M 9.98M 674M 10.08M 66.87M 26.05M 330M 26.76M 26.19M 1.14B P/E Ratio 2023
-3.09x
P/E Ratio 2024 -0.95x
Enterprise Value 59.25M 68.75M 54.56M 51.22M 96.17M 6.5B 97.19M 645M 251M 3.18B 258M 253M 11.03B EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Current year 0.1
Extreme 0.099
0.1
1 year 0.08
Extreme 0.085
0.83
3 years 0.08
Extreme 0.085
9.99
5 years 0.08
Extreme 0.085
31.7
10 years 0.08
Extreme 0.085
44.95
Manager TitleAgeSince
Chief Executive Officer 55 31/08/2016
Director of Finance/CFO - 11/12/2018
Chief Tech/Sci/R&D Officer - 31/03/2025
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 01/01/2017
Director/Board Member 79 19/04/2017
Date Insider Type Main position Quantity % Market Cap.
12/03/25Buy

Chairman

1,343,333 2.3347%
12/03/25Sell

Chairman

1,343,333 2.3347%
28/05/24Buy

Director

1,343,333 4.6122%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-87.69%-98.72% 7.08M
+0.07%-1.44%-17.93%+5.14% 118B
0.00%-2.04%+4.48%-9.92% 12.9B
-0.27%+2.64%+29.50%+91.49% 7.64B
-1.56%-2.13%-48.07%-72.02% 4.17B
-1.32%+4.41%+11.37%+31.99% 2.57B
-2.22%+8.61%-18.14%-17.65% 1.78B
-1.85%-8.17%+1.21%-17.07% 1.63B
+2.62%-6.01%+157.24%+127.66% 1.36B
Average -0.47%+1.70%+3.55%+4.55% 16.68B
Weighted average by Cap. -0.01%+2.02%-12.14%+7.15%

Financials

2023 2024
Net sales 3.84M 4.45M 3.53M 3.32M 6.23M 421M 6.29M 41.75M 16.27M 206M 16.71M 16.35M 714M 7.34M 8.52M 6.76M 6.35M 11.92M 806M 12.05M 79.91M 31.13M 395M 31.98M 31.3M 1.37B
Net income -53.87M -62.51M -49.6M -46.57M -87.44M -5.91B -88.37M -586M -228M -2.89B -235M -230M -10.03B -51.4M -59.64M -47.33M -44.44M -83.43M -5.64B -84.31M -559M -218M -2.76B -224M -219M -9.57B
Net Debt 49.64M 57.6M 45.71M 42.91M 80.57M 5.45B 81.42M 540M 210M 2.67B 216M 212M 9.24B 53.1M 61.62M 48.9M 45.91M 86.2M 5.83B 87.11M 578M 225M 2.85B 231M 226M 9.89B
Logo Carmat SA
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
153
  1. Stock Market
  2. Stocks
  3. ALCAR Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!